HIV/AIDS: Pneumocystis jiroveci pneumonia (PCP) Prophylaxis

Percentage of patients aged 6 weeks or older with a diagnosis of HIV/AIDS, who were prescribed Pneumocystis jiroveci pneumonia (PCP) prophylaxis

Date Reviewed: July 26, 2014
Support
    Group/Practice Individual Clinician

Measure Info

NQF 0405 CMS 160 NQF Endorsed
Measure Type
Process
Measure Steward
National Committee for Quality Assurance
Clinical Topic Area
HIV
Care Setting
Outpatient
Data Source
Other

ACP supports NQF 0405: “HIV/AIDS: Pneumocystis jiroveci pneumonia (PCP) Prophylaxis” because it aligns with current US Department of Health and Human Services guidelines for the prevention of opportunistic infections in those diagnosed HIV/AIDS.